The push toward healthcare price transparency started in earnest nearly 15 years ago, when the ACA highlighted the need for greater...

AI scribes for clinicians are clearly a compelling idea—but to what extent are adoption and results matching up? It can be hard to tell,...

In the last couple of months, we’ve been pulling up chairs with dozens of revenue cycle leaders to understand what’s keeping them awake...

The One Big Beautiful Bill Act (OBBBA) was signed into law by President Trump on July 4 after a narrow 218-214 vote in the House and...

Welcome to our sneak peek into some of the major things we’re studying across the remainder of this year. Here, we’re about to break down...

Quick rewind: our tour of the clinical data market that ended in a cliffhanger In Part 1 of this blog post (linked below if you missed...

A few weeks ago, we published a deep dive on shifts in physician employment models. The link to the full post is below for those who...

CMS and the OIG recently announced intention to audit health plans and providers in a set of initiatives that could recoup several billion dollars

Over the course of the past few weeks, all of the large, publicly-traded health plans have hosted their first set of earnings calls for...

Roughly half of the U.S. population gets health coverage through some form of government-sponsored insurance. And with control of both...

Health system leaders have long been interested in figuring out ways to monetize clinical data. It makes sense: if they could sell or license de-identified data in their EHRs to life science or tech companies, that would be very helpful from a revenue diversification perspective. Especially whenever core inpatient economics are under siege.  But, it’s always been an easier-said-than-done proposition. And now, maybe there's also a new spoiler in the mix, in the form of 'synthe

Later this week, we'll be convening live for this month's Board Briefing webinar to talk about the current state of the physician...